2,264
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain

, , , , &
Pages 295-303 | Received 02 May 2019, Accepted 19 Jun 2019, Published online: 25 Jul 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.